Placebo-only-controlled versus active-controlled trials of new drugs for nine common life-threatening diseases

Placebo-only-controlled versus active-controlled trials of new drugs for nine common life-threatening diseases

Sarah Sorscher, Azza AbuDagga, Sammy Almashat, Michael A Carome, Sidney M Wolfe Health Research Group, Public Citizen, Washington, DC, USA Purpose: The Food and Drug Administration (FDA) permits investigators to withhold active interventions from human subjects randomly assigned to control groups in...

Full description

Bibliographic Details
Main Authors: Sorscher S, AbuDagga A, Almashat S, Carome MA, Wolfe SM
Format: Article
Language:English
Published: Dove Medical Press 2018-04-01
Series:Open Access Journal of Clinical Trials
Subjects:
Drug Approval
Bioethics
Ethics
Medical
Food and Drug Administration
Research
Online Access:https://www.dovepress.com/placebo-only-controlled-versus-active-controlled-trials-of-new-drugs-peer-reviewed-article-OAJCT

Internet

https://www.dovepress.com/placebo-only-controlled-versus-active-controlled-trials-of-new-drugs-peer-reviewed-article-OAJCT

Similar Items